Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps

Benzinga

2024-12-17

Rockwell Medical, Inc. (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.

As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.

The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.

Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.

This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.

This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.

Also, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.

Price Action: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.

Read Next:

Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept

Image via Shutterstock.

Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.

Get the latest stock analysis from Benzinga?

ROCKWELL MEDICAL (RMTI): Free Stock Analysis Report

This article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2492962603"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492962603\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2492962603?lang=zh_TW&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/mCqFj4XahOwNwGjJizxT4w--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b","is_english":true,"pubTime":"2024-12-17 20:51","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2492962603","market":"us","top_or_hot":-1,"title":"Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps","media":"Benzinga","content":"<html><body><img height=\"675\" src=\"https://s.yimg.com/uu/api/res/1.2/K0GrINPdES.HdePBstby0g--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b\" width=\"1200\"/>\n<p><strong><a href=\"https://laohu8.com/S/RMTI\">Rockwell Medical</a>, Inc.</strong> (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.</p>\n<p>As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.</p>\n<p>The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.</p>\n<p>Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.</p>\n<p>This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.</p>\n<p>This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.</p>\n<p>Also, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.</p>\n<p><strong>Price Action</strong>: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.</p>\n<p><strong>Read Next</strong>:</p>\n<ul>\n<li><strong>Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept</strong></li>\n</ul>\n<p><em>Image via Shutterstock.</em></p>\n<p>Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. <strong>Click now to access unique insights</strong> that can set you ahead in today's competitive market.</p>\n<p>Get the latest stock analysis from Benzinga?</p>\n<ul>\n<li>ROCKWELL MEDICAL (RMTI): Free Stock Analysis Report</li>\n</ul>\n<p>This article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com</p>\n<p><i>© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</i></p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2024-12-17 20:51</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><img height=\"675\" src=\"https://s.yimg.com/uu/api/res/1.2/K0GrINPdES.HdePBstby0g--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b\" width=\"1200\"/>\n<p><strong><a href=\"https://laohu8.com/S/RMTI\">Rockwell Medical</a>, Inc.</strong> (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.</p>\n<p>As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.</p>\n<p>The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.</p>\n<p>Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.</p>\n<p>This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.</p>\n<p>This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.</p>\n<p>Also, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.</p>\n<p><strong>Price Action</strong>: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.</p>\n<p><strong>Read Next</strong>:</p>\n<ul>\n<li><strong>Asia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept</strong></li>\n</ul>\n<p><em>Image via Shutterstock.</em></p>\n<p>Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. <strong>Click now to access unique insights</strong> that can set you ahead in today's competitive market.</p>\n<p>Get the latest stock analysis from Benzinga?</p>\n<ul>\n<li>ROCKWELL MEDICAL (RMTI): Free Stock Analysis Report</li>\n</ul>\n<p>This article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com</p>\n<p><i>© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</i></p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/rockwell-medical-scores-multi-dialysis-125116099.html\">Benzinga</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"醫療保健用品","start_time":0,"source_url":"https://finance.yahoo.com/news/rockwell-medical-scores-multi-dialysis-125116099.html","article_id":"2492962603","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/mCqFj4XahOwNwGjJizxT4w--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d9cc73b1a8b7baa3508112a44c3ade6b"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492962603","pubTimestamp":1734439876,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Rockwell Medical, Inc.  shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.Last week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.This month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.This installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.Also, last mon","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","RMTI":"Rockwell Medical"},"translate_title":"罗克韦尔医疗公司获得多年透析协议；股票上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMTI":1},"content_text":"Rockwell Medical, Inc. (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services.\nAs per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms.\nThe agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwell Medical’s previously announced revenue estimates for 2025, with incremental price increases in subsequent years.\nLast week, the company announced the promotion of Jesse Neri to the post of Chief Financial Officer.\nThis month, Rockwell Medical disclosed a partnership with HydroCare in which HydroCare will purchase and install Rockwell’s DAMX45 dry acid concentrate mix system in dialysis water rooms.\nThis installation is expected to drive new sales for Rockwell’s dry acid hemodialysis concentrates.\nAlso, last month, the company inked a distribution deal with Nephro Group Dialysis Centers.\nPrice Action: RMTI shares are up 14.4% at $2.29 premarket at the last check Tuesday.\nRead Next:\n\nAsia Mostly Lower, Europe Markets Up As Dollar Strengthens Ahead Of Fed Rate Decision – Global Markets Today While US Slept\n\nImage via Shutterstock.\nUp Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.\nGet the latest stock analysis from Benzinga?\n\nROCKWELL MEDICAL (RMTI): Free Stock Analysis Report\n\nThis article Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps originally appeared on Benzinga.com\n© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}